Your browser doesn't support javascript.
loading
Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI.
Petrova, Anna; Chelysheva, Ekaterina; Shukhov, Oleg; Bykova, Anastasiya; Nemchenko, Irina; Gusarova, Galina; Tsyba, Nikolay; Julhakyan, Hunan; Shuvaev, Vasiliy; Fominykh, Mikhail; Martynkevich, Irina; Ionova, Tatyana; Turkina, Anna.
Afiliación
  • Petrova A; Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders, National Research Center for Hematology, Moscow, Russian Federation.
  • Chelysheva E; Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders, National Research Center for Hematology, Moscow, Russian Federation.
  • Shukhov O; Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders, National Research Center for Hematology, Moscow, Russian Federation.
  • Bykova A; Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders, National Research Center for Hematology, Moscow, Russian Federation.
  • Nemchenko I; Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders, National Research Center for Hematology, Moscow, Russian Federation.
  • Gusarova G; Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders, National Research Center for Hematology, Moscow, Russian Federation.
  • Tsyba N; Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders, National Research Center for Hematology, Moscow, Russian Federation.
  • Julhakyan H; Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders, National Research Center for Hematology, Moscow, Russian Federation. Electronic address: oncohematologist@mail.ru.
  • Shuvaev V; Russian Research Institute of Hematology and Transfusiology, Federal Biomedical Agency of Russia, Saint-Petersburg, Russian Federation; City Clinical Hospital n.a. V.V. Veresaev of the Moscow Department of Healthcare, Moscow, Russian Federation.
  • Fominykh M; Russian Research Institute of Hematology and Transfusiology, Federal Biomedical Agency of Russia, Saint-Petersburg, Russian Federation; Academic Chair of Hospital Therapy, Saint-Petersburg State University, Saint-Petersburg, Russian Federation.
  • Martynkevich I; Russian Research Institute of Hematology and Transfusiology, Federal Biomedical Agency of Russia, Saint-Petersburg, Russian Federation.
  • Ionova T; Chair of Quality of Life Unit, Saint-Petersburg State University Hospital, Saint Petersburg, Russian Federation; Quality of Life Monitoring Department, Multinational Center for Quality of Life Research, Saint Petersburg, Russian Federation.
  • Turkina A; Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders, National Research Center for Hematology, Moscow, Russian Federation.
Clin Lymphoma Myeloma Leuk ; 20(5): 267-271, 2020 05.
Article en En | MEDLINE | ID: mdl-32146103
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Abstinencia a Sustancias / Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia / Europa Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Abstinencia a Sustancias / Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia / Europa Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article